BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Vistide® 75 mg/ml concentrate for solution for infusion (cidofovir): Product recall

Active substance: cidofovir

The pharmaceutical manufacturer is sending out information to healthcare professionals on a product recall that is leading to shortages in the EU.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 122KB, File is accessible